News & Events
- Showing 1–23 of 23 items
ZeptoMetrix® releases new SARS-CoV-2 Recombinant (0831043) - designed to evaluate the performance of NATs for determination of SARS-CoV-2 E gene and portions of the ORF1ab gene region.
ZeptoMetrix® releases new SARS-CoV-2 Recombinant (0831042) - designed to evaluate the performace of NATs for determination of SARS-CoV-2 N gene.
ZeptoMetrix® newly inactivated and non-infectious NATtrol™ SARS-CoV-2 Recombinant is available for sale
ZeptoMetrix® has added 8 new products to its diverse collection of live microorganisms.
ZeptoMetrix® to release inactivated MRSA control for Molecular Diagnostic Quality Control. NATMRSA-6L
Trade Show information
Now available: Live Candida sojae Z128 (1mL), Candida auris Z845, titered (1mL), and Clostridium sporogenes Z355, titered (1mL) microorganisms have been added to the ZeptoMetrix inventory.
ZeptoMetrix® has added a new, inactivated NATtrol Respiratory Panel to its expanding inventory of Molecular QC.
IDbyDNA Announces Agreement with ZeptoMetrix to Support Quality Control Products.
ZeptoMetrix® to Release New Human Anti-HIV-1 Polyclonal Antibody.
ZeptoMetrix® to Release Inactivated Mycoplasma genitalium External Run Control for Molecular Diagnostic QC.
ZeptoMetrix® to Release Inactivated AdV/hMPV/HRV External Run Control for Molecular Diagnostic QC.
ZeptoMetrix® to Release Inactivated Parainfluenza External Run Control for Molecular Diagnostic QC.
Now available ZeptoMetrix® Chlamydia trachomatis Z499;Aus33;Serovar C titered bacteria and Candida kefyr Z110 titered fungal microorganisms.
ZeptoMetrix® to Release Inactivated Pneumonia Panels for Molecular Diagnostic QC.
RSV, Powassan, Measles, and Mumps
ZeptoMetrix® to Release Additional IVD/CE Marked Molecular Diagnostic Quality Controls.
ZeptoMetrix® to Release Additional P. jirovecii Molecular Control.
Two Group B Streptococcus molecular quality controls added to growing ZeptoMetrix IVD/CE offerings.
Blood Culture Identification Panels are designed to evaluate the performance of nucleic acid tests for determination of the presence of bacterial, and fungal nucleic acids.
ZeptoMetrix® Corporation names Shawn R. Smith it's new President and Chief Executive Officer.
ZeptoMetrix® and FIND Announce New Malaria Culture Panels to Develop High Sensitivity Malaria Test.